Psychopharmacology

, Volume 141, Issue 2, pp 182–188

Effect of a tyrosine-free amino acid mixture on regional brain catecholamine synthesis and release

  • Sarah F. B. McTavish
  • Philip J. Cowen
  • T. Sharp
ORIGINAL INVESTIGATION

DOI: 10.1007/s002130050823

Cite this article as:
McTavish, S., Cowen, P. & Sharp, T. Psychopharmacology (1999) 141: 182. doi:10.1007/s002130050823

Abstract

We report the effects of a tyrosine (and phenylalanine)-free amino acid mixture on tyrosine levels, ex vivo catecholamine synthesis and in vivo catecholamine release in brain regions of the rat. Administration of a tyrosine-free amino acid load reduced tissue levels of tyrosine (−50% after 2 h) in all brain regions examined (frontal cortex, hippocampus, striatum). The tyrosine-free amino acid mixture also reduced DOPA accumulation: this effect was most marked in striatum (−44%) and nucleus accumbens (−34%), areas with a predominantly dopaminergic innervation. Smaller decreases (−20–24%) were detected in other areas (cortex, hippocampus and hypothalamus). The effect on DOPA accumulation was prevented by supplementing the mixture with tyrosine/phenylalanine. The tyrosine-free amino acid mixture did not alter 5-HTP accumulation in any region. In microdialysis experiments, the tyrosine-free amino acid mixture did not consistently alter striatal extracellular dopamine under basal conditions but markedly, and dose-dependently, reduced the release of dopamine induced by amphetamine. In contrast, the tyrosine-free amino acid mixture did not alter either basal or amphetamine-evoked release of noradrenaline in hippocampus. Overall, these studies indicate that administration of a tyrosine-free amino acid mixture to rats depletes brain tyrosine to cause a decrease in regional brain catecholamine synthesis and release. Dopaminergic neurones appear to be more vulnerable to tyrosine depletion than noradrenergic neurones.

Key words Tyrosine depletion Catecholamine Dopamine Noradrenaline Microdialysis 

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Copyright information

© Springer-Verlag Berlin Heidelberg 1999

Authors and Affiliations

  • Sarah F. B. McTavish
    • 1
  • Philip J. Cowen
    • 2
  • T. Sharp
    • 1
  1. 1.University of Oxford Department of Clinical Pharmacology, Radcliffe Infirmary, Woodstock Road, Oxford, UKGB
  2. 2.University Department of Psychiatry, Warneford Hospital, Oxford, UK e-mail: trevor.sharp@clinpharm.ox.ac.uk, Fax: +44-1865-791712GB

Personalised recommendations